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s is a
ativecoPURPOSE: To assess the sensitivity and specificity for detecting macular disease with a new op-
tical biometry device with swept-source optical coherence tomography (SS-OCT) used before
cataract surgery.
SETTING: Hanusch Hospital, Vienna, Austria.
DESIGN: Consecutive case series.
METHODS: This study included patients with or without macular disease. All patients were scanned
using the new biometry device (IOLMaster 700), which allows a 1.0 mm central retinal scan using
SS-OCT technology. Also, all eyes were assessed using a dedicated retinal OCT device (RTVue)
on the same day. Two experienced examiners and 1 ophthalmology resident graded all scans
individually. Sensitivity and specificity for detecting macular disease were assessed, as were the
receiver operating characteristic curves.
RESULTS: Of the 125 eyes included, 5 were excluded from the analysis, 65 had a macular disease,
and 55 were healthy. The sensitivity of the biometry device was moderate (between 42% and 68%),
and the specificity was high (89% to 98%). Intraobserver reproducibility for assessing the biometry
device was 88.3%.
CONCLUSIONS: The biometry device with SS-OCT provided useful information concerning the
macula, especially for intraretinal fluid and macular holes. However, it cannot replace a macular
OCT device.
Financial Disclosure: None of the authors has a financial or proprietary interest in any material or
method mentioned.
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creativecommons.org/licenses/by-nc-nd/4.0/).One common challenge before cataract surgery is to
detect and document macular disease.1 Often, this
is performed by fundoscopy at the slitlamp only,
which does not allow for documentation and might
miss minor pathologic changes. To allow documen-
tation and a detailed morphologic analysis of the
macula, optical coherence tomography (OCT) scans
offering axial resolutions up to 10 mm are required,
which is usually not done routinely because of a
lack of time.2e Authors. Published by Elsevier Inc. on behalf of ASCRS and ESCRS.
n open access article under the CC BY-NC-ND license (http://
mmons.org/licenses/by-nc-nd/4.0/).A new optical biometry device (IOLMaster 700, Carl
Zeiss Meditec AG) uses swept- source OCT scanning
of the eye to measure not only biometric data but
also to perform a small central macular scan. The mac-
ular scan of the biometry device was introduced as a
quality control of the patient's fixation during biom-
etry. In the case of fixation, the fovea should be visible
in the macular scan. The question arises whether this
central retinal scan might be useful for screening of
macular pathology.http://dx.doi.org/10.1016/j.jcrs.2016.02.029
0886-3350
531MACULAR SCREENING USING AN OPTICAL BIOMETRY DEVICEPATIENTS AND METHODS
This study included patients who were measured with the
biometry device and a spectral domain OCT (SD-OCT)
(RTVue OCT, Optovue, Inc.) device on the same day.
Although patients were included consecutively in this study,
patients with macular pathologies were preferred. The aim
was to have at least 50% of patients with macular pathol-
ogies. Exclusion criteria were any opacities of the cornea or
a stage of very advanced cataract that would not allow per-
formance of OCT scans of the macula. All research and mea-
surements followed the tenets of the Declaration of Helsinki.Biometry DeviceThe IOLMaster 700 biometry device is a noncontact opti-
cal biometer that combines keratometric measurement with
full-eye OCT scanning that allows axial length measurement
as well as visualization of the anterior segment and a small
central 1.0 mm zone macular scan. It is based on swept-
source frequency-domain OCT, enabling a 44 mm scan
depth with 22 mm resolution in tissue. The speed of the mea-
surement allows acquiring full-eye length tomograms at
2000 A-scans/s.Scan AnalysisAll biometry device scans were exported without patient
information, such as name, date of birth, or diagnosis, and
each measured eye received a number in a randomized
fashion using the online randomizer.A According to these
random numbers, each scan was exported and presented
to 3 independent examiners. Two examiners (C.L., S.R.)
were experienced retinal specialists and vitreoretinal sur-
geons, whereas 1 examiner was a resident (S.M.) who was
familiar with OCT scans and preassessment visits before
cataract surgery. Analysis of the scans was performed inde-
pendently, and the results were not exchanged between the
examiners but directly sent to a fourth person (N.H.). For the
analysis, the following 3 questions were asked of the 2 ex-
perts: (1) Is the scan pathological (response options: yes,
no)? (2) What pathology is suspected? (3) Does the examiner
state a need for an additional full macular OCT scan?
Of the resident, 1 question was asked: Is the scan patho-
logical (response options: yes, no)? Furthermore, a fourth
examiner (N.H.) reanalyzed the SD-OCT scans 10 months
later to assess the interobserver reproducibility of the
SD-OCT device. In this case, only the classifications of “path-
ological” and “healthy” were used.
The full macular OCT scans performed with the SD-OCT
device were also exported without patient information, andSubmitted: August 30, 2015.
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J CATARACT REFRACT SURGthe order of scans was again randomized to be different from
the order of the biometry device scans. All macular scans
were analyzed concerning the type of pathology and the
location. The location was central, and therefore potentially
detectable with the biometry device, or outside the center.
For reproducibility purposes, 1 examiner (C.L.) reeval-
uated all biometry device scans 3 weeks after the baseline
analysis.Statistical AnalysisFor statistical analysis, Excel 2011 for Mac software (Mi-
crosoft Corp.) with a Statplus:mac pug-in (version 5.8.3.8,
Analystsoft) and an Xlstat 2012 plug-in (Addinsoft) were
used. For missing data, observations were excluded from
analysis. Descriptive data are always shown as the mean,
standard deviation, and range. The receiver operating char-
acteristic (ROC) curves were created using the online soft-
ware tool created by Johns Hopkins University,B plotting
the true-positive rate versus the false-positive rate. This basi-
cally means that sensitivity is given as a function of speci-
ficity. In addition, this program allows inclusion of the
uncertainty factor of the biometry device evaluation. There-
fore, we categorized the evaluation into 3 groups. Group 1
comprised cases in which both reviewers found pathology
in the biometry device scan. Group 3 comprised cases in
which both reviewers found the subject to be healthy. Group
2 represented cases in which the reviewers disagreed.
Furthermore, the sensitivity, specificity, accuracy, true-
positive rate, false-positive rate, true-negative rate, false-
negative rate, positive predictive value, and negative
predictive value were recorded for each examiner.
RESULTS
The study assessed 125 eyes of 125 patients. In 121
cases, successful SD-OCT scans were performed; the
SD-OCT scans were not evaluable in the other 4 cases
(in 3 cases because of fixation problems and in 1 case
because of a staphyloma and an off-axis measurement).
The mean age of the 121 patients was 60.0 yearsG 10.0
(SD) (range 27 to 84 years).
In 1 case, all 3 examiners were not able to evaluate
the biometry device scan at all. (This scan was
removed from further analysis.) In 5 further cases,
the 3 experts commented that the biometry device
scan was of bad quality but still decided on whether
it was pathological. The 5 difficult cases were not elim-
inated from the data set.
The remaining 120 cases were further analyzed.
Pathological macular findings were observed in the
SD-OCT scan in 65 cases (54.2%), whereas 55 cases
(45.8%) were found to show a normal macula. Interob-
server reproducibility of the SD-OCT device was high
for pathological (90.8%; 59 of 65 correct) and healthy
(96.4%; 53 of 55 correct) cases. Table 1 shows the fre-
quency of different macular pathologies.
In 8 cases, a pathology that did not affect the fovea
was found peripheral to the fovea on the SD-OCT
scan. As expected, none of these cases was detected
by the biometry device scan.- VOL 42, APRIL 2016
Table 1. Frequency ofmacular pathologies; some eyes hadmore
than 1 pathology.
Pathology
Number (%)
Frequency False Negatives
None (healthy controls) 55 (45.8) 6 (10.9)*
Epiretinal membrane 30 (25.0) 5 (16.7)
Macular/lamellar holes 5 (4.2)† 0
Drusen 11 (9.2) 3 (27.3)
Geographic atrophy 5 (4.2) 2 (40.0)
Intraretinal fluidz 16 (13.3) 2 (12.5)
*False positivesZ 10.9%
†Including 3 pseudoholes
zAge-related macular degeneration (n Z 11); diabetic macular edema
(nZ 4); Irvine-Gass syndrome (nZ 1)
Table 2. Evaluation of each single examiner. Two cases were not
included because all examiners mentioned that both scans were
of bad quality and no decision (pathological or not)was given for
both cases. Expert 1 and 2 were retinal experts with surgical
experience; Resident 1 was a resident in the third year.
Evaluation Expert 1 Expert 2 Resident 1
True positive (n) 45 31 28
False positive (n) 6 4 1
True negative (n) 48 50 53
False negative (n) 21 35 38
Sensitivity (%) 0.68 0.47 0.42
Specificity (%) 0.89 0.93 0.98
Accuracy (%) 0.78 0.675 0.68
True positive rate (%) 0.68 0.47 0.42
False positive rate (%) 0.11 0.07 0.02
True negative rate (%) 0.32 0.53 0.58
False negative rate (%) 0.89 0.93 0.98
Positive predictive value 6.14 6.34 22.91
Negative predictive value 0.36 0.57 0.59
532 MACULAR SCREENING USING AN OPTICAL BIOMETRY DEVICEThe biometry device scans’ evaluation was true
positive and false positive in between 28 to 45 cases
and 1 to 6 cases, respectively, and true negative
and false negative in between 48 to 53 cases and 21
to 38 cases, respectively. Table 2 shows the sensi-
tivity, specificity, accuracy, and other evaluation fac-
tors. Figure 1 shows the ROC curves. The fitted ROC
area was 0.87.
Both examiners (retinal experts) stated they would
perform an SD-OCT scan in all cases in which the
biometry device scan looked suspicious or was clearly
pathological. In addition to cases that were found to be
pathological or suspicious on the biometry deviceFigure 1. The ROC curve (continuous line). The dotted lines represent
the confidence interval (FPF Z false-positive fraction; TPF Z true-
positive fraction).
J CATARACT REFRACT SURGscan, 1 examiner mentioned that the scans were not
clear enough in 16 cases (13.3%) and he suggested per-
forming an SD-OCT scan in all these cases. Of these
16 cases, the SD-OCT scan showed an epiretinal mem-
brane in 8 cases, a myopic fundus in 2 cases, and a
health eye in 6 cases.
Examples for the biometry device and SD-OCT de-
vice are shown for an epiretinal membrane in
Figure 2, intraretinal fluid in Figure 3, a lamellar mac-
ular hole in Figure 4, a macular hole in Figure 5, and a
perifoveal atrophy in Figure 6.
Intraobserver reproducibility for the biometry de-
vice was good, with 88.3% (106/120 cases) of all cases
judged with the same diagnosis 3 weeks apart. Inter-
observer reproducibility between expert 1 and 2,
expert 1 and the resident, and expert 2 and the resident
was 78.3% (94/120 cases), 80.0% (96/120 cases), and
86.7% (104/120 cases), respectively.DISCUSSION
To our knowledge, this is the first study to assess the
integrated central macular scan of an optical biometry
device. Therefore, no comparison with previous publi-
cations is possible. In our study, although moderate
sensitivity was found, specificity was relatively high.
The difference between examiners could be explained
by slightly different judging patterns. One examiner
(expert 1) was more likely to classify a scan as patho-
logical than expert 2 and the resident. However, in
some cases all examiners agreed that they saw no pa-
thology, although the SD-OCT scan clearly showed a
pathological finding. These errors are most likely the- VOL 42, APRIL 2016
Figure 2. Comparison of the biometry device scan (A) and the SD-OCT scan in inverted color (B) for an epiretinal membrane.
533MACULAR SCREENING USING AN OPTICAL BIOMETRY DEVICEresult of the lower resolution and the smaller size of
the biometry OCT scan.
Healthy subjects were detected as such in most
cases. Some pathologies, such as macular holes, epire-
tinal membranes with traction, and macular edema,
were detected in most to all cases. However, other dis-
eases, such as geographic atrophy, were less likely to
be detected. This appears to be mainly the result of
the distortion of the biometry device scans, with theFigure 3. Comparison of the biometry device scan (A) and the SD-OCT sc
J CATARACT REFRACT SURGfovea appearing flatter than in conventional SD-OCT
scans and having a small scan zone of 1.0 mm.
Enlarging the scan zone and/or a modified graphical
representation with actual thickness measurement in
the fovea might enable the biometry device to be an
even better screening tool for macular pathology
before cataract surgery is performed.
Recently, detection data for cystoid macular changes
were published in a Cochrane review for the SD-OCT.3an in inverted color (B) for intraretinal fluid.
- VOL 42, APRIL 2016
Figure 4. Comparison of the biometry device scan (A) and the SD-OCT scan in inverted color (B) for a pseudomacular hole.
534 MACULAR SCREENING USING AN OPTICAL BIOMETRY DEVICEThis review pooled data from different studies showed
that the sensitivity and specificity of an SD-OCT to
detect diabetic macular edema were between 0.8 and
1.0, respectively. Although a large number of studies
have evaluated the sensitivity and specificity for spe-
cific factors, such as choroidal neovascularization activ-
ity,4 geographic atrophy activity,5 changes of macular
holes,6,7 and myopic foveoschisis,8 no sensitivity data
for detecting macular pathology in general are avail-
able. It should be taken into account that sensitivityFigure 5. Comparison of the biometry device scan (A) and the SD-OCT sc
J CATARACT REFRACT SURGand specificity of an OCT scan are mainly the result of
the resolution of the device.9
Stein et al.10 considered another parameterdthe
quality index (QI)dto evaluate the quality of OCT
scans. The QI is calculated based on image histogram
information. However, the calculation of this index is
not commonly used and the grading could be user-
dependent.
There were specific problems with the biometry
device scans. Because the macular scan is small, itan in inverted color (B) for a macular hole.
- VOL 42, APRIL 2016
Figure 6. Comparison of the biometry device scan (A) and the SD-OCT scan in inverted color (B) for a perifoveal atrophy.
535MACULAR SCREENING USING AN OPTICAL BIOMETRY DEVICEwas sometimes difficult to detect whether a scan was
simply not centered on the fovea or whether there
was an epiretinal membrane. As a consequence, the
2 analyzers asked for an additional SD-OCT in all
these cases.
Although severe geographic atrophy was detected
in most cases, mild to moderate atrophy was often
not, maybe because of the lower resolution of the
biometry device scan and the graphical representation
of the macula in the scan.
In some cases, a mild epiretinal membrane was
observed in the periphery of the macula, not
affecting the fovea. In these cases the size of the
biometry device scan was not large enough to detect
the membrane.
One improvement in the biometry-OCT scan
could be to color-code it, probably in a traffic-light
fashion. If the macular thickness and shape are
within the normal limits, a green light could be
shown. If there is a borderline finding, a yellow
traffic light could be shown. If there is a severe thick-
ening/thinning of the macula or a relevant change in
shape, a red flag should appear. This simple system
would make it much easier for the examiner to read
the scan.
In summary, the IOLMaster 700 biometry device
was beneficial in terms of detecting macular holes
and intraretinal fluid; however, other macular pa-
thologies, such as atrophy and epiretinal mem-
branes, were missed in several cases. Therefore,
conventional SD-OCT is necessary to refine the pre-
sumed diagnosis made based on scans from the
biometry device.J CATARACT REFRACT SURG - VWHAT WAS KNOWN
 Optical coherence tomography is 1 of the main diagnostic
tools for macular pathology recognition.
 The SS-OCT technique has been shown to have a high
resolution.WHAT THIS PAPER ADDS
 The SS-OCT macular scan included in the optical biometry
device was useful in detecting macular pathologies.
 Detection of macular holes and intraretinal fluid was good.
 Detection of epiretinal membranes and macular atrophy
was poor.
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